A new and highly specific monoclonal
antibody based ELISA for the detection of oligomeric Aβ42 in CSF,
cell supernatants, and tissue extracts
ADELAIDE, AUSTRALIA - Mar 4, 2014 - Biosensis is proud to
announce the release of its exclusive Oligomeric Amyloid
beta (oAβ) ELISA built upon the anti-amyloid beta
Aβ Oligomeric ELISA kit (Catalog No:
- This is the first oligomeric amyloid beta ELISA to take
advantage of MOAB-2's high specificity and avidity for beta amyloid
- Biosensis' oligomeric amyloid beta ELISA kit allows for the
detection of amyloid beta oligomers and complexes present in mouse
and human CSF and brain tissue extracts.
- Great dynamic range!
- Superb low end sensitivity!
- Validated by Literature!
Coming soon: MOAB-2 based Aβ/APOE & Aβ/APOJ
complex ELISAs ONLY from Biosensis.
Seewww.biosensis.comfor more details.